Insider Transactions in Q2 2023 at Prometheus Biosciences, Inc. (RXDX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2023
|
Helen C. Adams Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,674
-100.0%
|
-
|
|
Jun 16
2023
|
Keith W Marshall Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
87,973
-100.0%
|
-
|
|
Jun 16
2023
|
Fred Hassan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,123
-100.0%
|
-
|
|
Jun 16
2023
|
Joseph C Papa Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,000
-100.0%
|
-
|
|
Jun 16
2023
|
Joseph C Papa Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,278
-100.0%
|
-
|
|
Jun 16
2023
|
Judith L Swain Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,071
-100.0%
|
-
|
|
Jun 16
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
178,098
-100.0%
|
-
|
|
Jun 16
2023
|
Mary T Szela Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,071
-100.0%
|
-
|
|
Jun 16
2023
|
Mark Stenhouse Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
14,000
-100.0%
|
-
|
|
Jun 16
2023
|
Mark Stenhouse Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,754
-100.0%
|
-
|
|
Jun 16
2023
|
James Laur Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,071
-100.0%
|
-
|
|
Jun 16
2023
|
Martin Hendrix Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,071
-100.0%
|
-
|
|
Jun 02
2023
|
Mark C. Mc Kenna Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
122,531
+20.41%
|
$245,062
$2.3 P/Share
|
|
Jun 02
2023
|
Keith W Marshall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
78,162
+47.05%
|
$234,486
$3.1 P/Share
|
|
Jun 02
2023
|
Joseph C Papa Director |
BUY
Other acquisition or disposition
|
Indirect |
10,000
+50.0%
|
-
|
|
Jun 02
2023
|
Joseph C Papa Director |
SELL
Other acquisition or disposition
|
Direct |
10,000
-57.88%
|
-
|
|
Jun 01
2023
|
Mark Stenhouse Chief Operating Officer |
BUY
Other acquisition or disposition
|
Indirect |
14,000
+50.0%
|
-
|
|
Jun 01
2023
|
Mark Stenhouse Chief Operating Officer |
SELL
Other acquisition or disposition
|
Direct |
14,000
-52.42%
|
-
|
|
May 19
2023
|
Judith L Swain Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,071
+50.0%
|
-
|
|
May 19
2023
|
Mary T Szela Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,071
+50.0%
|
-
|
|
May 19
2023
|
Martin Hendrix Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,071
+50.0%
|
-
|
|
May 19
2023
|
James Laur Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,071
+50.0%
|
-
|
|
May 19
2023
|
Joseph C Papa Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,278
+11.65%
|
-
|
|
May 19
2023
|
Helen C. Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,174
+44.84%
|
-
|
|
May 19
2023
|
Fred Hassan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,123
+50.0%
|
-
|
|
Apr 05
2023
|
Keith W Marshall Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-50.48%
|
$1,080,000
$108.42 P/Share
|
|
Apr 05
2023
|
Keith W Marshall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+33.54%
|
$30,000
$3.7 P/Share
|